Question

I am a breastfeeding mother and i want to know if it is safe to use CHF 1251? Is CHF 1251 safe for nursing mother and child? Does CHF 1251 extracts into breast milk? Does CHF 1251 has any long term or short term side effects on infants? Can CHF 1251 influence milk supply or can CHF 1251 decrease milk supply in lactating mothers?

CHF 1251 lactation summary

CHF 1251 is safe in breastfeeding
  • DrLact safety Score for CHF 1251 is 1 out of 8 which is considered Safe as per our analyses.
  • A safety Score of 1 indicates that usage of CHF 1251 is mostly safe during lactation for breastfed baby.
  • Our study of different scientific research also indicates that CHF 1251 does not cause any serious side effects in breastfeeding mothers.
  • Most of scientific studies and research papers declaring usage of CHF 1251 safe in breastfeeding are based on normal dosage and may not hold true for higher dosage.
  • Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.

Answer by Dr. Ru: About CHF 1251 usage in lactation

It is excreted in breast milk in clinically non-significant amount and no problems have been observed in infants whose mothers took this medication. Levels in plasma and urine of such infants were undetectable. Having published less quantity of studies than with other drugs of the same group, safer alternatives may be preferable, especially in the neonatal period and in case of prematurity. The American Academy of Pediatrics rates it as usually compatible with breastfeeding.

Answer by DrLact: About CHF 1251 usage in lactation

Low amounts of CHF 1251 in milk and failure to detect CHF 1251 or its metabolites in the urine of 2 older infants indicates that it would not be expected to cause adverse effects in older breastfed infants. Because there is no published experience with CHF 1251 during breastfeeding in the newborn period, shorter-acting agents may be preferred while nursing a newborn or preterm infant.

CHF 1251 Side Effects in Breastfeeding

No adverse effects were found in the breastfed infant of a patient receiving 20 mg of CHF 1251 daily for 4 months starting the 9th month postpartum.[1]Four infants 3 to 4.5 months of age remained healthy during long-term therapy of their mothers with CHF 1251 20 mg daily.[2]
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.